Skip to content

Diaphragm Morphology and Respiratory Muscle Strength in Subacute Hemiplegic Patients

The Relationship Between Diaphragm Morphology and Respiratory Muscle Strength in Subacute Hemiplegic Patients: A Cross-Sectional Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07447804
Enrollment
38
Registered
2026-03-04
Start date
2026-02-26
Completion date
2026-09-26
Last updated
2026-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diaphragm Ultrasonography, Hemiplegia Following Ischemic Stroke, Stroke

Keywords

Ischemic Stroke, Diaphragm, Ultrasonography, Pulmonary Funtion, Subacute Hemiplegia, Diaphragm morphology, Respiratory muscle strength, Rehabilitation

Brief summary

The aim of this study is to determine the relationship between diaphragm morphology (diaphragm excursion, end-inspiratory and end-expiratory diaphragm thickness, and thickening fraction) and respiratory muscle strength (maximum inspiratory pressure - MIP and maximum expiratory pressure - MEP) in patients with subacute hemiplegia.

Detailed description

Stroke is a neurological condition that causes multidimensional impairments in motor, sensory, and pulmonary functions and is associated with a high long-term disability burden. After stroke, weakness particularly develops in the diaphragm and intercostal muscles; this results in reduced chest wall movements, ventilatory restriction, and decreased lung volumes. The diaphragm, the primary inspiratory muscle, being positioned higher on the paretic side and exhibiting reduced movement leads to decreased respiratory capacity and impaired cough effectiveness. Diaphragm ultrasonography is a method that allows noninvasive, reliable, and reproducible evaluation of diaphragm thickness, excursion, and functional changes. The relationship between ultrasound parameters and respiratory muscle strength is of clinical importance in determining the degree of respiratory muscle weakness and setting rehabilitation goals. Although it is known that post-stroke MIP and MEP values are significantly reduced compared to healthy individuals, the relationship between diaphragm morphology and respiratory muscle strength has been investigated to a limited extent, particularly in the subacute period. Demonstrating this relationship will make an important contribution to planning individualized respiratory rehabilitation in the early period.

Interventions

None listed

Sponsors

Fenerbahce University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 18-80 years * Clinical diagnosis of hemiplegia * Subacute phase (1-6 months post-onset) * Ability to tolerate diaphragm ultrasonography and MIP/MEP measurements * MMSE score ≥ 24 * Adequate level of consciousness and ability to cooperate

Exclusion criteria

* Respiratory comorbidities such as COPD, asthma, or interstitial lung disease * Diaphragmatic paralysis or severe chest wall deformity * Acute cardiopulmonary conditions preventing respiratory function testing * Severe cognitive impairment that may affect measurements * Inability to perform ultrasound assessment due to prior gastric or abdominal surgery

Design outcomes

Primary

MeasureTime frameDescription
Mini-Mental State Examination (MMSE)Baseline assessment at a single time point.The MMSE, developed by Folstein et al. in 1975, is a widely used, valid, and reliable test for assessing cognitive impairment. The MMSE is a 30-point, multi-item scale that evaluates five domains: orientation (10 points), registration (3 points), attention and calculation (5 points), recall (3 points), and language (9 points). In 2002, Güngen et al. demonstrated that the Turkish version of the MMSE is valid and reliable.
Respiratory Muscle Strength (MIP)Baseline assessment at a single time point.Respiratory muscle strength will be measured using an electronic, portable intraoral pressure device (MicroRPM, Micro Medical; United Kingdom). All measurements will be performed in the seated position. The nasal airway will be occluded using a nose clip, and an appropriate mouthpiece will be used. For MIP assessment, the patient will first perform a maximal expiration before placing the device in the mouth, followed by a maximal inspiratory effort (Müller maneuver) at maximum speed sustained for 1-3 seconds. This maneuver will be repeated three times, and the highest value will be recorded in cmH₂O.
Respiratory Muscle Strength (MEP)Baseline assessment at a single time point.Respiratory muscle strength will be measured using an electronic, portable intraoral pressure device (MicroRPM, Micro Medical; United Kingdom). All measurements will be performed in the seated position. The nasal airway will be occluded using a nose clip, and an appropriate mouthpiece will be used. For MEP assessment, the patient will first perform a maximal inspiration before placing the device in the mouth, followed by a maximal expiratory effort (Valsalva maneuver) at maximum speed sustained for 1-3 seconds. This maneuver will be repeated three times, and the highest value will be recorded in cmH₂O.
Diaphragmatic UltrasonographyBaseline assessment at a single time point.Diaphragm excursion will be assessed using M-mode ultrasonography, and diaphragm thickness and contractility will be measured using B-mode ultrasonography. Patients will be evaluated in the supine position. Diaphragm thickness will be measured at end-expiration from the 9th intercostal space along the anterior axillary line using a 7-MHz linear transducer. Diaphragm motion during normal and deep breathing will be assessed with a 3.5-MHz curved transducer from the right hemidiaphragm. The difference between inspiratory and expiratory measurements will be analyzed, and diaphragm thickening fraction will be calculated.

Countries

Turkey (Türkiye)

Contacts

CONTACTSümeyye Akçay, Asst. Prof.
smyye.akcy@gmail.com+905424002553
PRINCIPAL_INVESTIGATORSümeyye Akçay, Asst. Prof.

Fenerbahçe University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026